Abbott India Ltd vs Astal Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 12, 2026

Key Highlights

The Latest Trading Price of Abbott India Ltd is ₹ 26898 as of 12 May 15:30 . The P/E Ratio of Abbott India Ltd changed from 46.1 on March 2021 to 46.2 on March 2025 . This represents a CAGR of 0.04% over 5 yearsThe P/E Ratio of Astal Laboratories Ltd changed from 437.5 on March 2021 to 8.4 on March 2025 . This represents a CAGR of -54.64% over 5 years The Market Cap of Abbott India Ltd changed from ₹ 31850 crore on March 2021 to ₹ 65302 crore on March 2025 . This represents a CAGR of 15.44% over 5 yearsThe Market Cap of Astal Laboratories Ltd changed from ₹ 3.47 crore on March 2021 to ₹ 74.72 crore on March 2025 . This represents a CAGR of 84.77% over 5 years The revenue of Abbott India Ltd for the Mar '26 is ₹ 1785 crore as compare to the Dec '25 revenue of ₹ 1793 crore. This represent the decline of -0.49% The revenue of Astal Laboratories Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 52.27 crore. This represent the decline of -100% The ebitda of Abbott India Ltd for the Mar '26 is ₹ 556.44 crore as compare to the Dec '25 ebitda of ₹ 533.23 crore. This represent the growth of 4.35% The ebitda of Astal Laboratories Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 3.59 crore. This represent the decline of -100% The net profit of Abbott India Ltd changed from ₹ 328.01 crore to ₹ 394.93 crore over 8 quarters. This represents a CAGR of 9.73% The net profit of Astal Laboratories Ltd changed from ₹ 1.69 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Abbott India Ltd changed from 84.61 % on March 2021 to 71.36 % on March 2025 . This represents a CAGR of -3.35% over 5 yearsThe Dividend Payout of Astal Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Abbott India Ltd

Abbott India Ltd Share Price Overview Abbott India Ltd share price history records the movement of the stock in various phases of the market.
Company developments, as well as the general trends in the pharmaceutical industry, have influenced this movement.
As a healthcare-oriented company, the stock tends to respond to fluctuations in the demand of drugs, regulatory activities, and the general mood of investors.
The past performance of the stock gives the investors an idea of how it has reacted to the change in earnings, product portfolio development, and significant company occurrences at various times. Long-Term Performance The stock price performance of Abbott India Ltd has seen phases of fluctuation over time, with a 18% CAGR over the last 10 years.
This reflects movement across different market conditions, with periods of strength and correction.

About Astal Laboratories Ltd

Astal Laboratories Limited was formerly incorporated as a public company limited by shares on August 03, 1993 in the name of Macro International Limited.
The Company was taken over under SEBI takeover guidelines in 2022 and the main objects of the Company was changed to 'Manufacture and Sales of Pharmaceutical Intermediates and Bulk Drugs'.
Subsequently the name of the Company was changed to Astal Laboratories Limited in May, 2024.
The Company is now a subsidiary of Aceso Research Labs LLP. The Company was promoted by the Kanpur based business house of Parasrampurias.
The Company set up a departmental store at Plaza Kalpana, Birhana Road, Kanpur, offering products such as readymade garments, electronic items, leather items, stationery, books, fast food centre etc. During 1996-97, the departmental store project succeeded, only Saree Division and Archies Card Division was in operation.

FAQs for the comparison of Abbott India Ltd and Astal Laboratories Ltd

Which company has a larger market capitalization, Abbott India Ltd or Astal Laboratories Ltd?

Market cap of Abbott India Ltd is 57,158 Cr while Market cap of Astal Laboratories Ltd is 347 Cr

What are the key factors driving the stock performance of Abbott India Ltd and Astal Laboratories Ltd?

The stock performance of Abbott India Ltd and Astal Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Abbott India Ltd and Astal Laboratories Ltd?

As of May 12, 2026, the Abbott India Ltd stock price is INR ₹26898.1. On the other hand, Astal Laboratories Ltd stock price is INR ₹82.3.

How do dividend payouts of Abbott India Ltd and Astal Laboratories Ltd compare?

To compare the dividend payouts of Abbott India Ltd and Astal Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.